Dulaglutide (Trulicity, GLP-1 receptor agonist)-Therapeutic peptides (hIgG4 Fc fusion) drug benchmark for in-vivo/in-vitro study
Cat No.: GMP-Bios-peptide-002
Product Name: Dulaglutide
Dulaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist consisting of GLP-1(7-37) covalently linked to an Fc fragment of human IgG4. Dulaglutide, sold under the brand name Trulicity among others, is a medication used for the treatment of type 2 diabetes in combination with diet and exercise. It is also approved in the United States for the reduction of major adverse cardiovascular events in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors.
Delivery impact due to the Coronavirus Outbreak
With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.
|Catalog No.||Package||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Resource (expression host)||mammalian|
|Specics/Isotypes||Recombinant protein fused to an Fc fragment of human IgG4|
|Biological Activity||Dulaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist consisting of GLP-1(7-37) covalently linked to an Fc fragment of human IgG4.|
|Purity||Purity: ≥95% (SDS-PAGE)|
|Application||Therapeutic peptides drug benchmark or raw material for peptide drugs or peptide conjugation drugs discovery and development.|
|Predicted Molecular Mass||3213.2|
|Formulation||Lyophilized from sterile PBS, PH 7.4|
|Storage||Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.|